1
|
Sridhara R, Marchenko O, Jiang Q, Pazdur R, Posch M, Redman M, Tymofyeyev Y, Li X(N, Theoret M, Shen YL, Gwise T, Hess L, Coory M, Raven A, Kotani N, Roes K, Josephson F, Berry S, Simon R, Binkowitz B. Type I Error Considerations in Master Protocols With Common Control in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion. Stat Biopharm Res 2021. [DOI: 10.1080/19466315.2021.1906743] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
| | | | | | | | - Martin Posch
- Medical Statistics at the Medical University of Vienna, Vienna, Austria
| | | | | | | | | | | | | | | | | | | | | | - Kit Roes
- Swedish Medical Products Agency (MPA), Uppsala, Sweden
| | | | | | | | | |
Collapse
|